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Objectives: Antimicrobial-resistant infections are a major global health issue. Ease of antimicrobial access in
developing countries is proposed to be a key driver of the antimicrobial resistance (AMR) epidemic despite a lack
of community antimicrobial usage data.
Methods: Using a mixed-methods approach (geospatial mapping, simulated clients, healthcare utilization, lon-
gitudinal cohort) we assessed antimicrobial access in the community and quantified antimicrobial usage for
childhood diarrhoea in an urban Vietnamese setting.
Results: The study area had a pharmacy density of 15.7 pharmacies/km2 (a pharmacy for every 1316 people).
Using a simulated client method at pharmacies within the area, we found that 8% (3/37) and 22% (8/37) of out-
lets sold antimicrobials for paediatric watery and mucoid diarrhoea, respectively. However, despite ease of phar-
macy access, the majority of caregivers would choose to take their child to a healthcare facility, with 81%
(319/396) and 88% (347/396) of responders selecting a specialized hospital as one of their top three preferences
when seeking treatment for watery and mucoid diarrhoea, respectively. We calculated that at least 19%
(2688/14427) of diarrhoea episodes in those aged 1 to ,5 years would receive an antimicrobial annually; how-
ever, antimicrobial usage was almost 10 times greater in hospitals than in the community.
Conclusions: Our data question the impact of community antimicrobial usage on AMR and highlight the need
for better education and guidelines for all professionals with the authority to prescribe antimicrobials.
Introduction
Antimicrobial resistance (AMR) is rapidly becoming a global public
health issue.1 In the past decade, many of the key antimicrobials
on which we have come to rely in human medicine are in the pro-
cess of losing, or have already lost, their effectiveness in treating
infections caused by bacterial pathogens.2,3 AMR is a complex sci-
entific, political, economic and social issue, and although devel-
oped countries are leading research efforts to tackle the problems,
the greatest impact of AMR is currently being felt in low- and mid-
dle-income countries (LMICs).4–6 AMR is magnified in LMICs as
antimicrobial access and usage, poor sanitation and limited access
to clean water are amongst the principal drivers. Therefore, unre-
stricted access to low-cost antimicrobials combined with a high
burden of infectious disease, limited diagnostic capacity and large
urbanizing populations demanding better medical care has cre-
ated a favourable environment for propagating antimicrobial-
resistant bacteria in LMICs.7,8
Antimicrobials are frequently used indiscriminately to treat
common human diseases, of which diarrhoea is a major contribu-
tor. It has been estimated that the worldwide burden of diarrhoea
was .1.7 billion episodes in 2010, with the vast majority of these
episodes arising in children in LMICs.9 The aetiological agents of
diarrhoea are broad and can induce an array of symptoms and
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severity, including watery, mucoid and bloody diarrhoea.
Currently, the WHO recommends oral rehydration solution (ORS)
and zinc for all diarrhoea, and antimicrobial treatment for those
with more severe symptoms.10,11 A large disease burden, com-
bined with a lack of financial and diagnostic resources in LMICs,
means that the causative agent is rarely or never identified.12 In
Asia, this lack of a confirmative diagnosis results in the empirical
use of antimicrobials in the community or a healthcare facility.
However, many of those receiving antimicrobials for diarrhoea
may not require them,13 as the disease is generally self-limiting
and frequently of viral aetiology,12 and AMR in diarrhoeagenic bac-
teria is now highly prevalent in LMICs in Asia.3,13
Despite the perceived haphazard use of antimicrobials in LMICs,
antimicrobial access and usage for the treatment of common
infections in vulnerable populations has seldom been accurately
estimated. Such data are vital for understanding how AMR may
emerge, spread and be sustained, and are critical for targeting
public health interventions to reduce antimicrobial usage. Vietnam
is a rapidly developing LMIC in Southeast Asia with a population of
.90 million people.14 An increasing population, a high infectious
disease burden and a largely unregulated antimicrobial market
combine to make Vietnam the ideal location for investigating anti-
microbial access and usage. Diarrhoeal disease is a common child-
hood illness in Vietnam, a country with high recorded antimicrobial
use in the healthcare system.13,15 By combining geospatial ana-
lysis, community and pharmacy surveys, and a longitudinal cohort
study, we aimed to investigate antimicrobial access and usage for
paediatric diarrhoeal disease in the community and the healthcare
system in an urban setting in Vietnam.
Materials and methods
Ethics
Ethics approvals were provided by the Oxford University Tropical Research
Ethics Committee (OxTREC approval 5110-16) and the institutional review
board of the Ho Chi Minh City (HCMC) University of Medicine and Pharmacy
(No. 220/DHYD-HD). Written informed consent was obtained from all par-
ticipants (from parents and guardians if the participant was,18 years old).
Study setting and design
With an estimated population of.8 million people, HCMC is the largest city
in Vietnam.16 HCMC is divided into five rural districts and 19 urban districts
that cover an area of 19 km2; the urban districts had a mean population
density of 13394 people/km2 in 2016.16 We selected District 8 (hereinafter
referred to as the study area), with 16 wards and a population density of
22522 people/km2, as the location for sampling owing to its urban setting
and central location (Figure S1, available as Supplementary data at JAC
Online, and Table 1).16 To assess antimicrobial access and usage we trian-
gulated data from a prospective paediatric cohort17 and conducted a
cross-sectional study with several components: (i) geographical mapping
of all pharmacies and healthcare facilities in the study area; (ii) a pharmacy
practice survey to assess medication suggested by retail pharmacies for
paediatric diarrhoea; and (iii) a self-reported caregiver community survey
on the management and antimicrobial treatment of paediatric diarrhoea.
The coordinates of all pharmacies in the study area were recorded and
entered into EpiCollect5.18 Vietnam administrative boundaries were down-
loaded from Global Administrative Divisions Map (https://gadm.org/down
load_country_v3.html). Vietnam population data rasters (population per
0.01 km2) were downloaded from WorldPop (http://www.worldpop.org.uk/
data/WorldPop_data/AllContinents/130_metadata.html; 100 m resolution),
and satellite imagery of Vietnam was downloaded from ESRI (http://www.
esrivn.com/en/index.html) basemaps. All geospatial mapping was con-
ducted using ArcGIS version 10.2 (Redlands, CA, USA). Euclidean distance to
the nearest pharmacy and kernel density plots for pharmacy density (i.e.
pharmacies per 0.01 km2) were estimated for the study area using the
‘Euclidean distance’ and ‘Kernel’ ArcGIS tools, respectively.
Pharmacy practice survey
We conducted a survey of pharmacy behaviour using an unbiased observa-
tional technique for assessing dispensed medication known as ‘simulated
client methodology’.19–22 Two ‘mystery shoppers’ with no healthcare train-
ing role-played as caregivers and approached pharmacies in a sub-region
(Ward 5) of the study area to seek medical advice and treatment for two
childhood diarrhoea scenarios. Scenario 1 (watery diarrhoea): a mother
attending the pharmacies in the study area to buy medication for a child
aged 2 years. The child has had 4–5 loose stool episodes within the previous
24 h. The child has no fever, and no blood or mucus in stools. Scenario 2
(mucoid diarrhoea with fever): a mother attending the pharmacies in the
study area to buy medication for a child aged 2 years. The child has had 4–5
loose stool episodes within the previous 24 h. The child had a mild fever and
mucus in the stool. Pharmacy-prescribed drugs were labelled anonymous-
ly, and then were classified by a clinician and confirmed by a qualified
pharmacist (scripts in Table S1). In addition we aimed to investigate
whether antimicrobials were being sold without a doctor’s prescription by
sending a mystery shopper to pharmacies in the study area to buy cipro-
floxacin. This was a specific scenario in which the shopper requested this
antimicrobial and did not provide any information about for what or whom
the treatment was required.
Self-reported behaviour survey
We performed a community survey to capture the self-reported behaviour
of parents and caregivers in managing diarrhoea in their children aged
Table 1. Pharmacies and healthcare clinics in the various wards in the
study area
Populationa
Pharmacy density
(per 10000 people)
Ward in
District 8
Healthcare
facilities Pharmacies all
1 to ,5
years all
1 to ,5
years
1 7 10 25782 944 3.88 105.93
2 20 29 20694 843 14.01 344.01
3 15 16 24803 1139 6.45 140.47
4 51 36 42200 2284 8.53 157.62
5 46 48 40177 2538 11.95 189.13
6 15 34 30144 1353 11.28 251.29
7 12 28 31685 1414 8.84 198.02
8 4 5 9024 444 5.54 112.61
9 8 14 21564 1194 6.49 117.25
10 15 14 15841 836 8.84 167.46
11 7 5 7591 294 6.59 170.07
12 7 10 16653 816 6.00 122.55
13 12 7 8809 480 7.95 145.83
14 4 6 20575 1144 2.92 52.45
15 10 13 39623 2354 3.28 55.23
16 6 26 41010 1243 6.34 209.17
Total 239 301 396175 19320 7.59 142
aData from HCMC Demographic Department, 30 June 2017.
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between 1 and 5 years. The surveyed population consisted of participants
residing in the study area. We randomly sampled a representative popula-
tion stratified by 16 wards and with registered children aged ,5 years.
Local health authorities accompanied and assisted in community visits.
Mothers or caregivers were asked a short questionnaire regarding their
choice of care if their child had diarrhoea in simulated scenarios similar
to those described in the pharmacy behaviour study. We surveyed 396
parents or caregivers (Table S2). Results from these questionnaires are
reported as means (interquartile range) and frequencies (%) for continuous
and categorical variables respectively. For comparisons between groups,
we used Fisher’s exact test for categorical variables, and the Mann–
WhitneyU-test for continuous variables (significant P0.05).
Quantifying antimicrobial use for diarrhoea
We considered that antimicrobial usage for diarrhoeal disease was depend-
ent on the number of diarrhoeal episodes for which medical treatment was
sought, and how likely antimicrobials were to be prescribed for diarrhoeal
treatment. Figure 1 outlines the parameters, the source of data and the cal-
culations used to quantify antimicrobial usage for diarrhoea in children aged
1–5 years. The annual number of diarrhoeal episodes presenting at pharma-
cies was the product of (A) the total number of children aged 1–5 years in the
study area, (B) the incidence rate of diarrhoea episodes per child-year, and
(E) the proportion of parents or caregivers selecting to first take their child to a
pharmacy. The annual number of diarrhoeal episodes presenting at hospitals
was multiplied by (A) the total number of children aged 1–5 years living in the
study area and (C) the incidence rate of diarrhoea episodes presenting at hos-
pital per child-year. Parameter (A) was derived from recent census data from
the HCMC Demographic department (30 June 2017). Incidence rates (B) and
(C) were estimated from a prospective diarrhoeal cohort conducted between
2014 and 2016 that actively followed up 748 children residing in the study
area.17 The proportion of parents or caregivers seeking pharmacies as their
first choice (E) was derived from the self-reported behaviour survey of parents
and caregivers. To quantify the likelihood of prescribing antimicrobials for
diarrhoeal treatment at a hospital or a pharmacy, we used antimicrobial
treatment data from (D) the prospective cohort study17 (from hospital files)
and (F) the pharmacy behaviour study, respectively.
Results
The distribution of outlets selling antimicrobials
We mapped a total of 301 pharmacies and 243 private or
public healthcare clinics in the study area (Table 1 and Figure 2a).
Figure S1 shows the geographical location of the study area. The
distribution of pharmacies was not uniform and ranged from 0 to
61 pharmacies/km2, with a mean density of 15.7 pharmacies/km2.
The majority of outlets were located on main thoroughfares in the
north of the study area (Figure 2a). The population pharmacy
density equated to 7.59 pharmacies/10000 people, corresponding
to a pharmacy for every 1316 people. The number of pharmacies
within the population varied from 0 to 38.2 pharmacies/10000
people, with four high-density areas (.30 outlets/10000 people)
(Figure 2b). The high density of pharmacy shops epitomized rou-
tine access to antimicrobials in this community and equated to
.75% of the study area population living within 250 m of an outlet
selling antimicrobials (Figure 2c).
Pharmacy prescribing practices for diarrhoea
We surveyed 48 pharmacy shops (37 were open when visited) in a
ward within the study area (Figure S1), and used two different
scenarios for paediatric diarrhoea. In the first scenario (watery
diarrhoea), the number of prescribed medications ranged from
one to five, with the majority (65%; 24/37) of pharmacies prescrib-
ing two different medications (Figure 3a). The median total cost
for each pharmacy visit was 17000 Vietnamese dong (VND) (US
$123000 VND); range 7000–54000 VND. A total of 46 different
types and brands of medications were sold, which could be broadly
categorized into 11 classes: anti-motility, zinc, anti-emetics, anti-
secretory, probiotics, ORS, antimicrobial, antipyretic, adsorbent, un-
labelled and others. Unlabelled treatments were prescribed in
16% (6/37) of pharmacy visits, with probiotics (81%; 30/37) and
adsorbents (68%; 25/37) being the most commonly sold treat-
ments. Antimicrobials were prescribed by 3/37 (8%) pharmacies
for watery diarrhoea (Figure 3b).
In the second scenario (mucoid diarrhoea with fever), 53 differ-
ent medications were sold by the 37 pharmacies; undefined/un-
labelled medications were sold in 49% (18/37) of pharmacy visits
(Figure 3b). Probiotics (81%; 30/37) and adsorbents (51%; 19/37)
remained the most common medications prescribed, but the pro-
portion of pharmacies prescribing an antimicrobial increased to
22% (8/37). There was also an increase in the number of different
mediations sold for mucoid diarrhoea in comparison with those
Data sources Census data
Children aged
1–5 years
Total number of
children aged
1–5 years
19 320
(a) (b) (c) (d) (e) (f)
watery = 0.536 watery = 0.112
mucoid = 0.210 mucoid = 0.116
watery = 42%
watery = 22%mucoid = 65%
mucoid = 16%
watery = 42%
mucoid = 65%
Diarrhoea
Incidence of
diarrhoea
(episodes per
person year)
Incidence of diarrhoe
attending hospital
(episodes per
person year)
Hospital
Antimicrobial access
Parameters
Prospective diarrhoeal cohort study
Self-reported
behaviour
survey
Pharmacy Antimicrobials
Antimicrobials
Antimicrobial use
in hospital
Children with
diarrhoea attending
a pharmacy
Antimicrobial use
in pharmacy
Pharmacy
practice
survey
Figure 1. Estimating antimicrobial usage for diarrhoea in children aged 1–5 years in pharmacies and hospital. Diagram outlining the sources of data,
parameters, and calculations used to quantify antimicrobial usage for diarrhoea in children aged 1–5 years in this population. Note each of the
parameters have been given an initial (A–F), which informs the calculations in Table 3.
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Pharmacy density
(per 0.01 km2)
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(per 10 000 people)
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0–250 m
District 8 border
0–0.053
(a)
(b)
(c)
0.054–0.13
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0.23–0.32
0.33–0.43
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N
Figure 2. The geographical distribution of pharmacies in the Ho Chi Minh City study area. Maps of district 8 in Ho Chi Minh City. (a) The point locations
of pharmacies and the kernel distribution of pharmacy shop density. Green points identify the pharmacy shops and pharmacy density is determined
by colour intensity (see key). (b) The distribution of pharmacy shops density per 10 000 inhabitants. The greater the intensity of red the higher the
number of pharmacy shops per 10 000 people (see key, areas in grey are those with no data owing to missing data in the population raster). (c) The
geographical areas in District 8 that are within 250 m of a pharmacy. Red shaded areas are locations in which residents live with 250 m of a location
selling antimicrobials.
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sold to treat watery diarrhoea (Figure 3a), with a higher proportion
of pharmacies selling a combination of three (41%; 15/37), four
(14%; 5/37) or five (5%; 2/37) medications. Despite there being a
greater number of medications sold, the cost to caregivers in this
scenario was not substantially greater than with watery diarrhoea
(median 18000 VND; range 3000–31000 VND).
There was considerable disparity in the type of antimicrobials
sold in the 37 surveyed pharmacies, with pharmacies prescribing
trimethoprim sulphate, sulphonamides, fluoroquinolones, macro-
lides and cephalosporins. When the mystery shopper returned to
the same pharmacies a week later and asked to buy ciprofloxacin,
100% (37/37) of the vendors sold the requested antimicrobial. This
medication was consistently sold without dosing advice and with-
out the caregiver having to provide information as to why the anti-
microbial was required. Generic ciprofloxacin was sold in a range of
different packaging from 14 different manufacturers in two differ-
ent concentrations.
Antimicrobial usage surveys in caregivers
To evaluate how local residents in the study area access antimicro-
bials and to understand their knowledge, attitudes and practices
regarding antimicrobial usage, we surveyed 396 individuals
(Table S2). The majority (82%; 325/396) of the interviewees were
women and the median age was 39 years (range 19–87 years).
Ten percent of participants (39/381) indicated some background in
healthcare. The majority (69%; 243/351) had an average house-
hold income (1300000 and9000000 VND/household/month),
with 21% (74/351) reporting being in a poor financial situation
(,1300000 VND/household/month). Most caregivers/parents
(60%; 232/386) had 2 children living in the household. Many
(59%; 231/394) reported that their children had received
medication for a medical condition within the last month, of which
approximately half (47%; 109/231) were reported to be an
antimicrobial.
We found that a majority of interviewed parents and caregivers
had limited knowledge about antimicrobials. Many assumed that
antimicrobials could be generically used to treat coughing (46%;
181/396), fever (35%; 137/396), colds (30%; 118/396), headaches
(21%; 81/396) and diarrhoea (19%; 76/396). Approximately half
(51%; 203/396) of the parents and caregivers agreed with the
statement ‘some infections can be difficult to treat if there is anti-
microbial resistance’, and 59% (233/396) agreed with the state-
ment ‘resistance can occur if you do not take a sufficient dose’.
In self-reported prescribing, more than half of parents and care-
givers (54%; 213/394) said they had at some time purchased anti-
microbials from pharmacies, with many of them (85%; 182/213)
buying antimicrobials within the 30 days prior to the interview
(Table S3).
Diarrhoeal treatment-seeking behaviour
Figure 4 shows the top three preferences for places where parents
and caregivers would seek healthcare advice if their children had
either of the two previously described diarrhoeal disease scenarios.
In both scenarios, the most common first choice was to treat their
children at home. However, a specialized hospital was the most
common option, with 81% (319/396) and 88% (347/396) of res-
ponders selecting this as one of their top three preferences for
treatment of watery and mucoid diarrhoea, respectively. Visiting a
local pharmacy as a first choice ranked third for watery diarrhoea
and second for mucoid diarrhoea. Overall, visiting a pharmacy was
selected as one of the top three preferences by 45% (180/396)
and 34% (134/396) of caregivers for watery and mucoid diarrhoea,
respectively (Figure 4). We observed that parents (rather than a
caregivers) and those of younger age were more likely to take their
children to a pharmacy than a hospital for watery diarrhoea
(P"0.015 and P"0.051, respectively). Similarly, parents (rather
than caregivers) were significantly more likely to take their children
to a pharmacy than a hospital for mucoid diarrhoea (Table 2).
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Figure 3. Medications sold by pharmacies in the study area for paediatric diarrhoea. (a) Rotated histogram showing the number and proportion (x-
axis) of the 37 pharmacies visited during the ‘mystery shopper’ simulated client method selling between 1 and 5 medications (y-axis) for watery and
mucoid diarrhoea, respectively. (b) Rotated histogram showing the number and proportion (x-axis) of the 37 pharmacies visited during the ‘mystery
shopper’ simulated client method selling different mediations (y-axis) for watery and mucoid diarrhoea, respectively.
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Quantifying antimicrobial use for diarrhoea
We lastly aimed to calculate antimicrobial usage in the community
and in hospitals for diarrhoeal disease in children aged between 1
and 5 years (Figure 1). From following 748 children and quantifying
episodes of diarrhoea over a 2 year period in the diarrhoea cohort,
we estimated the total annual incidence of watery and mucoid
diarrhoea to be 536 (95% CI 463–609) and 210 (95% CI 154–267)
per 1000 child-years, respectively (Table 3). The annual incidences
of watery and mucoid diarrhoea resulting in hospital attendance
were 112 (95% CI 83–141) and 116 (95% CI 83–149) per 1000
child-years, respectively. Among the diarrhoeal episodes resulting
in hospital attendance, 66/159 (42%) watery episodes and 107/
164 (65%) mucoid episodes received antimicrobial treatment in
hospital. We therefore estimated the total number of diarrhoeal
episodes within the study area in this age group to be 10355 (95%
CI 8945–11765) and 4057 (95% CI 2975–5158) per year for watery
and mucoid diarrhoea, respectively.
Combining data from the surveys of the self-reported behaviour
and the pharmacy practice, we estimated that the annual number
of diarrhoeal episodes in children aged 1–5 years that would re-
ceive antimicrobial treatment at pharmacies were 184 (95% CI
159–209) for watery diarrhoea and 144 (95% CI 105–183) for mu-
coid diarrhoea (Table 3). However, data from the diarrhoea cohort
indicated that the number of paediatric diarrhoeal cases that
resulted in an antimicrobial administration in a hospital was ap-
proximately 5 [898 (95% CI 673–1130)] and 10 times higher [1462
(95% CI 1046–1878)] for watery and mucoid diarrhoea, respect-
ively (Table 3). In total, we estimated that at least 19% (2688/
14 427) of diarrhoeal episodes in children aged 1–5 years in the
study area would receive an antimicrobial annually.
Discussion
AMR infections are increasingly common throughout Asia, a trend
that may be driven in part by access to antimicrobials.23–25
Vietnam illustrates this trend; it is the world’s 15th most populous
country, urbanization has increased from 28% in 2014 to 34.9% in
2017 and it is predicted to have a population of .100 million peo-
ple by 2025.26 Antimicrobial dispensing in Vietnam is known to be
poorly regulated, leading to inappropriate prescribing and self-
medication for a number of common infections, including fever
and acute respiratory infections.27,28 We selected childhood diar-
rhoea, which is common in Vietnam, and among the top motives
for seeking healthcare in HCMC, as a syndrome for which to assess
antimicrobial use.12,29–31
The overall density of pharmacies in the community in HCMC
is high (7.59/10000 people), and outnumbers the number of
pharmacy staff that have been trained at any level (assistant or
university degree) in the city (5.98/10000 people).32 This density
of pharmacies in HCMC is reflective of the general pattern in
LMICs, for example Sabde et al.33 reported a comparable ratio in
an urban area of India (5.84/10000 people). However, the num-
ber of pharmacy outlets in HCMC is more than double the mean
density of pharmacies in other areas of the world, such as Europe
(3.06/10000 people)34 and other parts of Southeast Asia
(3.02/10000 people),34 and three times higher than that of some
countries in the Western Pacific (2.28/10000 people)34 and the
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Figure 4. Healthcare utilization for paediatric diarrhoea by caregivers. Pyramid plot showing the number and proportions of 396 individual caregivers
or parents of children aged,5 years residing in the study area (x-axis) selecting the various healthcare services (y-axis) as first, second or third
choices (see key for shading) for watery and mucoid diarrhoea.
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USA (2.11/10000 people).35 This ratio of pharmacies is six times
higher than in LMICs in Africa.34 Ease of access to retail pharma-
cies may improve equity in the use of medication but it allows ac-
cess to treatments that should be better controlled, especially
when pharmacy staff are underqualified and/or fail to follow ap-
propriate guidelines.
Our study demonstrated the common sale of antimicrobials
without prescription for paediatric diarrhoeal disease in the
Table 3. The burden of diarrhoea and antimicrobial treatment for diarrhoea in children aged 1–5 years
Diarrhoea episodes per year (95% CI)
Parameter total
attending
hospital
receiving an
antimicrobial in hospital
attending a
pharmacy
receiving an
antimicrobial at a pharmacy
Calculationa (A% B) (A% C) (A% C% D) (A% B% E) (A% B% E% F)
Diarrhoea type
watery 10355 (8945–11765) 2163 (1622–2724) 898 (673–1130) 2275 (1965–2584) 184 (159–209)
mucoid 4057 (2975–5158) 2241 (1603–2878) 1462 (1046–1878) 667 (489–848) 144 (105–183)
Total 14427 (12636–16 219) 4404 (3560–5249) 2359 (1884–2834) 2945 (2585–3305) 329 (282–375)
aCalculation derived from parameters described in Figure 1.
Table 2. The demographic characteristics of parents and caregivers who chose a pharmacy or a hospital as first choice for a child with diarrhoea
Watery diarrhoea Mucoid diarrhoea
pharmacy (n"87) hospital (n"89) P valuea pharmacy (n"65) hospital (n"142) P valuea
Female sex 73/87 (84) 72/89 (81) 0.693 55/65 (85) 113/142 (80) 0.448
Role of parent (not caregivers) 54/86 (63) 39/89 (44) 0.015 43/64 (67) 69/142 (49) 0.015
Age in years, mean (IQR) 38 (30–50)b 40 (32–57) 0.051 38 (31–50)c 40 (32–56)d 0.198
Healthcare trained 7/83 (8) 11/83 (13) 0.461 4/63 (6) 16/138 (12) 0.316
Employment 87/87 (100) 89/89 (100) 0.661 65/65 (100) 142/142 (100) 0.943
worker 10/87 (11) 10/89 (11) 6/65 (9) 16/142 (11)
officer 6/87 (7) 6/89 (7) 5/65 (8) 10/142 (7)
health staff 2/87 (2) 6/89 (7) 1/65 (2) 6/142 (4)
business owner 15/87 (17) 10/89 (11) 11/65 (17) 23/142 (16)
housewife 35/87 (40) 34/89 (38) 29/65 (45) 56/142 (39)
other (retired) 19/87 (22) 23/89 (26) 13/65 (20) 31/142 (22)
Education12 years 75/87 (86) 68/88 (77) 0.171 55/65 (85) 115/141 (82) 0.695
Monthly income (VND)e 0.406 0.739
1.3 million 15/78 (19) 14/80 (18) 11/57 (19) 20/127 (16)
1.3–9 million 59/78 (76) 57/80 (71) 42/57 (74) 95/127 (75)
.9 million 4/78 (5) 9/80 (11) 4/57 (7) 12/127 (9)
Only 1 child 36/84 (43) 37/84 (44) 1.000 21/65 (32) 61/134 (46) 0.091
Only 1 child aged ,5 years 68/85 (80) 71/86 (83) 0.699 49/65 (75) 105/134 (78) 0.718
Age of first child, years, mean (IQR) 3 (2–4) 2/87 (2–4)f 0.486 3 (2–4) 3/140 (2–4)g 0.553
Infections in previous month 57/86 (66) 44/86 (51) 0.063 43/65 (66) 73/139 (53) 0.071
Medication in previous month 60/87 (69) 51/87 (59) 0.207 45/65 (69) 83/141 (59) 0.167
Antimicrobials in previous month 24/60 (40) 26/70 (37) 0.857 18/41 (44) 46/118 (39) 0.585
All values shown are n/N (%) unless otherwise indicated.
aP values calculated using Fisher’s exact test for categorical variables and the Mann–Whitney U-test for continuous variables. Significant P values are
highlighted in bold.
bNumber of respondents"81.
cNumber of respondents"60.
dNumber of respondents"139.
eMonthly income ,1300000 VND/month is determined to be poor and below average (as suggested by the Vietnamese government), whereas in-
come9000000 VND/month is considered a good monthly income and above average.
fNumber of respondents"87.
gNumber of respondents"140.
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community in HCMC. Notably, we estimated that antimicrobial
sales for paediatric diarrhoeal disease in the community in HCMC
were lower than in several other LMICs, such as Ethiopia (26%;
58/223),20 and other Asian countries, such as Pakistan (14%)36
and Thailand (52%).37 The low proportion of antimicrobials dis-
pensed for acute watery diarrhoea in HCMC is corresponds with a
declining trend in antimicrobials being used for watery diarrhoea in
Vietnam. Limited available data suggest that the proportion of
antimicrobials dispensed for acute watery disease has decreased
over the last 20 years, from 45% of cases in 1997,38 to 14% in
2013,39 to 8% (3/37) here. This trend may result from a substantial
improvement in practices in pharmacies to alleviative antimicro-
bial prescribing and the impact of resistance. However, despite an
array of public health engagement and intervention projects, anti-
microbials still remain the most inappropriate drugs dispensed
from retail pharmacies in Vietnam.40 It is additionally worth noting
that previous studies have suggested that antimicrobial usage is
greater in rural areas than in urban areas.28
We predicted that the diarrhoeal disease management in the
community in HCMC would be comparable with that of other
LMICs, where antimicrobials are dispensed without further consid-
eration.36–38,41,42 However, we found that the total number of diar-
rhoeal episodes that would receive an antimicrobial in a hospital
was 5–10 times higher than in retail pharmacies. Our findings are
consistent with a recent finding in this setting, where 85% of
paediatric diarrhoeal patients admitted to hospital were prescribed
an antimicrobial.13 It has been estimated that one-third of anti-
microbial prescriptions in Vietnamese hospitals may be inappropri-
ate,43 a level that could promote AMR in various bacterial
pathogens. It is apparent that in a setting with limited-to-no diag-
nostic testing, this clinical approach is considered optimal for pre-
venting complications and saving lives. There is a large demand for
hospital care in HCMC, and as doctors have limited time to make
clinical decisions, such an approach is deemed effective and less
time consuming. Therefore, there is a clear requirement for tests
that can identify children at the more severe end of the disease
spectrum and can distinguish between a viral and a bacterial
infection.
Our study has some limitations. We likely underestimated the
overall antimicrobial use as our calculation did not take into ac-
count antimicrobial use in facilities other than specialized hospi-
tals. Additionally, relying on the choice of attending pharmacy as
the first option only and the practice of selling antimicrobials in a
small number of pharmacies from two scenarios may underesti-
mate antimicrobial sales in pharmacies. Even though we
employed a thorough process to quantify antimicrobial use for
diarrhoea, our data extrapolation may contain errors as we com-
piled data from several sources. In addition, as we aimed to assess
antimicrobial dispensing only, we did not record or evaluate the
retailer’s consulting abilities for using these treatments, which
may reflect local antimicrobial handling practices. Lastly, our com-
bined studies focused on diarrhoeal diseases in young children
only, and we recognize that our approach offers limited under-
standing of antimicrobial usage in other populations and other
presentations.
We conclude that the density of pharmacy retailers is extreme-
ly high in urban HCMC. Antimicrobial usage for diarrhoeal disease
in children is more common in hospitals than via community phar-
macies. Given these findings, combined with the general low level
of knowledge regarding antimicrobials among parents and care-
givers, we predict a high burden of antimicrobial overuse in
Vietnam. We advocate better education, training and guidelines
for antimicrobial usage and AMR for all health professionals pre-
scribing antimicrobials in Vietnam.
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